Article Correctness Is Author's Responsibility: Scientists link common immune cell to failure of checkpoint inhibitors in lung cancer

(Fred Hutchinson Cancer Research Center) For many lung cancer patients, the best treatment options involve checkpoint inhibitors, but the drugs only help a small subset of patients. A new study links the most abundant white blood cell to failure of checkpoint inhibitors.